Stewart K G, Zhang Y, Davidge S T
Departments of Obstetrics/Gynecology and Physiology, Perinatal Research Centre, University of Alberta, Edmonton, Canada.
Hypertension. 2000 Jun;35(6):1242-7. doi: 10.1161/01.hyp.35.6.1242.
During aging, the vascular endothelium changes functionally and morphologically. Although previous studies have shown that endothelium-derived eicosanoids increase vessel tone in aging, the precise mechanism(s) has not been fully determined. We hypothesized that aging would increase prostaglandin H synthase (PGHS)-dependent vasoconstriction as well as decrease nitric oxide-dependent relaxation. Mesenteric arteries from 3-month-old (n=9) and 12-month-old (n=14) female Sprague-Dawley rats were studied in a myograph system. Aging significantly blunted the endothelium-dependent relaxation response to methacholine compared with young rats (EC(50)=7.77x10(-8) versus 2.68x10(-8) mol/L, P<0. 05). Nitric oxide synthase inhibition reduced methacholine-induced relaxation in the young (P<0.05) but had no effect in the aging group. Specific inhibition of the PGHS-1 isoform did not significantly affect methacholine-mediated relaxation in the young or aged groups. However, PGHS-2 inhibition greatly enhanced relaxation to methacholine (1.59x10(-8) versus 7.77x10(-8) mol/L, P<0.01) in the aged group only, restoring vessel function to that of the young. In the aged group, inhibition of the prostaglandin H(2)/thromboxane A(2) receptor enhanced methacholine-dependent relaxation similar to that of PGHS-2 inhibition. Moreover, arterial expression of PGHS-2 protein increased with age. In summary, nitric oxide-dependent modulation of vessel function decreased with age, PGHS-1 did not significantly affect vessel tone in either the young or aging group, and PGHS-2 greatly increased vasoconstriction in aging. Thus, we have identified enhanced PGHS-2-mediated vasoconstriction in aging and therefore suggest that inhibition of this isoform is potentially a new target for therapeutic intervention to improve vascular function.
在衰老过程中,血管内皮在功能和形态上都会发生变化。尽管先前的研究表明,内皮衍生的类二十烷酸会增加衰老过程中的血管张力,但其确切机制尚未完全确定。我们推测,衰老会增加前列腺素H合酶(PGHS)依赖性血管收缩,同时减少一氧化氮依赖性舒张。在肌动描记系统中研究了3个月大(n = 9)和12个月大(n = 14)雌性Sprague-Dawley大鼠的肠系膜动脉。与年轻大鼠相比,衰老显著减弱了对乙酰甲胆碱的内皮依赖性舒张反应(半数有效浓度[EC50] = 7.77×10⁻⁸对2.68×10⁻⁸mol/L,P < 0.05)。一氧化氮合酶抑制降低了年轻大鼠中乙酰甲胆碱诱导的舒张(P < 0.05),但对衰老组没有影响。PGHS-1同工型的特异性抑制对年轻或老年组中乙酰甲胆碱介导的舒张没有显著影响。然而,仅在老年组中,PGHS-2抑制极大地增强了对乙酰甲胆碱的舒张(1.59×10⁻⁸对7.77×10⁻⁸mol/L,P < 0.01),使血管功能恢复到年轻大鼠的水平。在老年组中,抑制前列腺素H₂/血栓素A₂受体增强了乙酰甲胆碱依赖性舒张,类似于PGHS-2抑制。此外,PGHS-2蛋白的动脉表达随年龄增加。总之,一氧化氮依赖性血管功能调节随年龄下降,PGHS-1在年轻或衰老组中均未显著影响血管张力,而PGHS-2在衰老过程中极大地增加了血管收缩。因此,我们发现衰老过程中PGHS-2介导的血管收缩增强,因此建议抑制该同工型可能是改善血管功能的治疗干预新靶点。